Intuitive Surgical guidance impresses, shares rise


Intuitive Surgical (ISRG) is out with preliminary Q4 and FY13 results.

Q4: Revenue seen at $576M (-5% Y/Y), consensus is $548.6M; instruments and accessories revenue, $268M (+6% Y/Y); da Vinci Surgical Systems revenue seen at $205M (-23% Y/Y); systems sold, 138 versus 175 in Q4 2012.

FY13: Revenue seen at ~$2.265B (+4% Y/Y), consensus is $2.24B; instruments and accessories revenue, $1.033B (+14% Y/Y); da Vinci Surgical Systems revenue see at $835M (-11%), systems sold, 546 versus 620 in 2012. (PR)

Summer Street's Mark Land is reportedly cautious, noting that the seasonality of elective procedures may have contributed to Q4 results.

ISRG +12% premarket.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs